1 Followers on Owler

Valence Advantage Life Sciences Fund

is a late-stage investments... Read more
OverviewCompetitorsInvestmentsNews & Insights

Valence Advantage Life Sciences Fund

is a late-stage investments... Read more
Valence Advantage Life Sciences Fund Founder & CEO: Rachel Leheny

Founder & CEO

Rachel Leheny

CEO Approval Rating

69/100

06/2012

Investment CompanyIndependent Company

Health Care Equipment & Services
Add Sector

Est. Annual Revenue
$14.5M
Est. Employees
10
Investments
5

News

Mar 11, 2021
BioSpace
Valence Advantage Life Sciences Fund: CalciMedica Announces $21 Million Series D Financing
May 25, 2020
FinSMEs
Valence Advantage Life Sciences Fund: CalciMedica Raises $15M in Series C Financing
Mar 04, 2014
DEVICESPACE
Valence Advantage Life Sciences Fund: San Francisco Based-Invuity, Inc. Raises $36 Million In Series E Funding
Mar 04, 2014
BUSINESS WIRE
Press Release: Valence Advantage Life Sciences Fund : Invuity® Raises $36 Million in Series E Financing

Valence Advantage Life Sciences Fund Competitors

1Daoust Associates
2Health Care Investment Visions
3MichaelBass Group
4Finnerty Economic Consulting
5Allianceperformance
6Putnam
7Gilfus Education Group
8Westchester Consulting
9Northshore Management Company
10Baroma
Unlock 8 + competitors

Trending Companies